Prospective Quality of Life in Men Choosing Active Surveillance Compared to Those Biopsied but not Diagnosed with Prostate Cancer

Journal of Urology

Volumn 196, Issue 2, 2016, Pages 392-398

  Pham, Khanh N ^a   Cullen, Jennifer ^e,f,g   Hurwitz, Lauren M ^e,f   Wolff, Erika M ^a   Levie, Katherine E ^e,f   Odem Davis, Katherine ^b,c   Banerji, John S ^a   Rosner, Inger L ^e,h   Brand, Timothy C ^d,e   L'Esperance, James O ^e,i   Sterbis, Joseph R ^e,j   Porter, Christopher R ^a,e  

^a Virginia Mason MS Center   (United States)

^b Statistical Center   (United States)

^c Institute of Translational Health Sciences   (United States)

^d MADIGAN ARMY MEDICAL CENTER   (United States)

^e Center for Prostate Disease Research   (United States)

^f HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^g Uniformed Services University of the Health Sciences   (United States)

^h WALTER REED ARMY MEDICAL CENTER   (United States)

ⁱ NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^j TRIPLER ARMY MEDICAL CENTER   (United States)

more..

Author keywords

image guided biopsy; prostatic neoplasms; quality of life; survival rate; watchful waiting

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; SHORT FORM 36; SURVIVAL RATE; WATCHFUL WAITING; FACTUAL DATABASE; FOLLOW UP; HEALTH STATUS INDICATOR; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PROSTATE TUMOR;

ADULT; AGED; BIOPSY, NEEDLE; DATABASES, FACTUAL; FOLLOW-UP STUDIES; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; WATCHFUL WAITING;

EID: 84979663341     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2016.02.2972     Document Type: Article

References (30)

1. 1 Siegel, R., Ward, E., Brawley, O., et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 61, 2011, 212.
2. 2 Hayes, J.H., Ollendorf, D.A., Pearson, S.D., et al. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA, 304, 2010, 2373.
3. 3 Klotz, L., Vesprini, D., Sethukavalan, P., et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol, 33, 2015, 272.
4. 4 Weiner, A.B., Patel, S.G., Etzioni, R., et al. National trends in the management of low and intermediate risk prostate cancer in the United States. J Urol, 193, 2015, 95.
5. 5 Sanda, M.G., Dunn, R.L., Michalski, J., et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med, 358, 2008, 1250.
6. 6 Huang, G.J., Sadetsky, N., Penson, D.F., Health related quality of life for men treated for localized prostate cancer with long-term followup. J Urol, 183, 2010, 2206.
7. 7 Litwin, M.S., Flanders, S.C., Pasta, D.J., et al. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology, 54, 1999, 503.
8. 8 Litwin, M.S., Pasta, D.J., Yu, J., et al. Urinary function and bother after radical prostatectomy or radiation for prostate cancer: a longitudinal, multivariate quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol, 164, 2000, 1973.
9. 9 Jeldres, C., Cullen, J., Hurwitz, L.M., et al. Prospective quality-of-life outcomes for low-risk prostate cancer: active surveillance versus radical prostatectomy. Cancer, 121, 2015, 2465.
10. 10 Bergman, J., Litwin, M.S., Quality of life in men undergoing active surveillance for localized prostate cancer. J Natl Cancer Inst Monogr, 242, 2012, 2012.
11. 11 Klotz, L., Active surveillance, quality of life, and cancer-related anxiety. Eur Urol, 64, 2013, 37.
12. 12 Bellardita, L., Valdagni, R., van den Bergh, R., et al. How does active surveillance for prostate cancer affect quality of life? A systematic review. Eur Urol, 67, 2015, 637.
13. 13 Brassell, S.A., Dobi, A., Petrovics, G., et al. The Center for Prostate Disease Research (CPDR): a multidisciplinary approach to translational research. Urol Oncol, 27, 2009, 562.
14. 14 Ware, J.E. Jr., SF-36 health survey update. Spine (Phila Pa 1976), 25, 2000, 3130.
15. 15 Wei, J.T., Dunn, R.L., Litwin, M.S., et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology, 56, 2000, 899.
16. 16 Norman, G.R., Sloan, J.A., Wyrwich, K.W., Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care, 41, 2003, 582.
17. 17 Litwin, M.S., Health related quality of life in older men without prostate cancer. J Urol, 161, 1999, 1180.
18. 18 Bellardita, L., Rancati, T., Alvisi, M.F., et al. Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance. Eur Urol, 64, 2013, 30.
19. 19 Wilcox, C.B., Gilbourd, D., Louie-Johnsun, M., Anxiety and health-related quality of life (HRQL) in patients undergoing active surveillance of prostate cancer in an Australian centre. BJU Int, 113, 2014, 64.
20. 20 van den Bergh, R.C., Essink-Bot, M.L., Roobol, M.J., et al. Anxiety and distress during active surveillance for early prostate cancer. Cancer, 115, 2009, 3868.
21. 21 Daubenmier, J.J., Weidner, G., Marlin, R., et al. Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance. Urology, 67, 2006, 125.
22. 22 Punnen, S., Cowan, J.E., Dunn, L.B., et al. A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer. BJU Int, 112, 2013, E67.
23. 23 Burnet, K.L., Parker, C., Dearnaley, D., et al. Does active surveillance for men with localized prostate cancer carry psychological morbidity?. BJU Int, 100, 2007, 540.
24. 24 Thong, M.S., Mols, F., Kil, P.J., et al. Prostate cancer survivors who would be eligible for active surveillance but were either treated with radiotherapy or managed expectantly: comparisons on long-term quality of life and symptom burden. BJU Int, 105, 2010, 652.
25. 25 Seiler, D., Randazzo, M., Leupold, U., et al. Protocol-based active surveillance for low-risk prostate cancer: anxiety levels in both men and their partners. Urology, 80, 2012, 564.
26. 26 Vasarainen, H., Lokman, U., Ruutu, M., et al. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial. BJU Int, 109, 2012, 1614.
27. 27 Johansson, E., Steineck, G., Holmberg, L., et al. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol, 12, 2011, 891.
28. 28 Aizer, A.A., Paly, J.J., Zietman, A.L., et al. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. J Clin Oncol, 30, 2012, 3071.
29. 29 Silveira, E., Taft, C., Sundh, V., et al. Performance of the SF-36 health survey in screening for depressive and anxiety disorders in an elderly female Swedish population. Qual Life Res, 14, 2005, 1263.
30. 30 Punnen, S., Cowan, J.E., Chan, J.M., et al. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry. Eur Urol, 68, 2015, 600.